TY - JOUR AU - Weigert, Verena AU - Jost, Tina AU - Hecht, Markus AU - Knippertz, Ilka AU - Heinzerling, Lucie AU - Fietkau, Rainer AU - Distel, Luitpold V. PY - 2020 DA - 2020/08/18 TI - PARP inhibitors combined with ionizing radiation induce different effects in melanoma cells and healthy fibroblasts JO - BMC Cancer SP - 775 VL - 20 IS - 1 AB - PARP inhibitors niraparib and talazoparib are FDA approved for special cases of breast cancer. PARP is an interesting repair protein which is frequently affected in cancer cells. We studied the combined action of talazoparib or niraparib with ionizing radiation in melanoma cells and healthy fibroblasts. SN - 1471-2407 UR - https://doi.org/10.1186/s12885-020-07190-9 DO - 10.1186/s12885-020-07190-9 ID - Weigert2020 ER -